Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to $8.0 million.

  • Corcept Therapeutics' Other Non-Current Assets rose 1543.09% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 1543.09%. This contributed to the annual value of $6.6 million for FY2024, which is 105.49% up from last year.
  • Corcept Therapeutics' Other Non-Current Assets amounted to $8.0 million in Q3 2025, which was up 1543.09% from $8.3 million recorded in Q2 2025.
  • Corcept Therapeutics' Other Non-Current Assets' 5-year high stood at $8.3 million during Q2 2025, with a 5-year trough of $1.8 million in Q2 2022.
  • In the last 5 years, Corcept Therapeutics' Other Non-Current Assets had a median value of $5.1 million in 2022 and averaged $5.4 million.
  • As far as peak fluctuations go, Corcept Therapeutics' Other Non-Current Assets plummeted by 5570.05% in 2022, and later skyrocketed by 14062.16% in 2023.
  • Over the past 5 years, Corcept Therapeutics' Other Non-Current Assets (Quarter) stood at $3.1 million in 2021, then skyrocketed by 64.06% to $5.1 million in 2022, then increased by 29.32% to $6.5 million in 2023, then increased by 1.05% to $6.6 million in 2024, then grew by 21.77% to $8.0 million in 2025.
  • Its Other Non-Current Assets stands at $8.0 million for Q3 2025, versus $8.3 million for Q2 2025 and $6.6 million for Q1 2025.